Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: PJT‐173497
Weston Brain Institute
Grant: TR192065
National Institutes of Health
Grant: NIH‐NINDS R01NS110024
National Institutes of Health
Grant: R01NS049442 to O.A
National Institutes of Health
Grant: NIH R01NS134902 to L.F
Alzheimer's Association
Grant: AARG 17‐505136 to L.F
NIH HHS
Grant: NIH-NINDS R01NS110024
Alzheimer's Association
Grant: AARG 17-505136 to L.F
NINDS NIH HHS
Grant: R01 NS134902
Fostering Joint International Research
Grant: 17KK0197 to S.M
Grant-in-Aid for Scientific Research
Grant: 21K06759 to S.M
CIHR
Grant: PJT-173497
NINDS NIH HHS
Grant: R01 NS110024
NINDS NIH HHS
Grant: R01 NS049442
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01NS110024-05
The Role of SUMOylation in Tau-Mediated Pathology
National Institutes of Health
Grant: 5R01NS134902-02
Role of SUMOylation in Mitochondrial/Synaptic Axis Dysfunction Induced by Abnormal Tau in FTD
National Institutes of Health
Grant: 5R01NS049442-09
SUMOylation and Amyloid-beta elevation
Japanese Society for the Promotion of Science
Japanese Society for the Promotion of Science (JSPS)
Fields of Study
MeSH Terms
Keywords